BioHarvest Sciences Inc. ... (BHST)
NASDAQ: BHST
· Real-Time Price · USD
9.50
0.28 (3.06%)
At close: Aug 15, 2025, 12:39 PM
BioHarvest Sciences Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.66M | -12.91M | -17.19M | -16.23M | -18.39M | -12.56M | -8.14M | -10.34M | -9.86M | -11.24M | -10.18M | -9.3M | -5.16M | -9.84M | -11.19M | -9.99M | -13.12M |
Depreciation & Amortization | 1.45M | 1.25M | 1.13M | 988.27K | 840.34K | 837.24K | 813.24K | 782.1K | 761.48K | 699.48K | 645.02K | 577.13K | 463.11K | 387.11K | 314.57K | 291.14K | 285.78K |
Stock-Based Compensation | 468K | 601K | 586K | 578K | 572K | 563K | 776K | 997K | 1M | 1.35M | 1.9M | 2.32M | 3.15M | 3.37M | 3M | 2.91M | 2.04M |
Other Working Capital | 1.52M | 1.23M | 1.57M | 1.29M | 861K | 1.86M | 1.55M | 806K | 1.62M | 691K | 983K | 1.49M | 793K | 793K | 517K | -1.14M | -225K |
Other Non-Cash Items | 267.49K | 4.93M | 8.67M | 7.85M | 8.88M | 1.88M | -2.2M | -989K | -1.01M | 239K | -1.36M | -1.81M | -5.85M | -627K | 2.19M | 1.99M | 6.46M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -37.45K | -544.42K | -484.5K | 277.61K | -355.26K | 744.74K | 701K | -12.79K | 685.48K | -321.41K | -52.41K | 247.59K | -725.93K | -109.04K | -106.69K | -1.42M | -88.65K |
Operating Cash Flow | -6.53M | -6.68M | -7.29M | -6.53M | -8.45M | -8.52M | -8.03M | -9.54M | -8.39M | -9.24M | -9.02M | -7.95M | -8.09M | -6.79M | -5.75M | -6.19M | -4.41M |
Capital Expenditures | -3.29M | -2.83M | -2.73M | -2.66M | -1.32M | -1.47M | -1.45M | -1.29M | -1.24M | -1.26M | -1.35M | -1.57M | -1.77M | -1.64M | -1.44M | -946K | -429K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -188.01K | -192K | -185K | -225K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -3.48M | -3.03M | -2.92M | -2.89M | -1.32M | -1.47M | -1.45M | -1.28M | -1.24M | -1.26M | -1.35M | -1.57M | -1.77M | -1.64M | -1.44M | -946K | -429K |
Debt Repayment | 5.5M | 2.04M | 13.35M | 14.7M | 19.16M | 19.91M | 8.41M | 10.33M | 5.99M | 5.27M | 2.9M | -298K | -366K | -332K | -234.16K | -168.43K | -108.34K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -666.31K | -574.4K | -7.03M | -5.69M | -1.16M | -413.1K | 6.16M | 7.89M | 5.48M | 4.76M | 4.69M | 4.43M | 2.44M | 3.54M | 3.58M | 862.62K | 778.72K |
Financial Cash Flow | 10.01M | 6.78M | 11.34M | 12.68M | 12.82M | 13.56M | 8.78M | 11.43M | 8.71M | 8.14M | 5.85M | 7.26M | 5.18M | 10.77M | 11.19M | 8.66M | 8.97M |
Net Cash Flow | -1.05M | -2.96M | 1.21M | 3.36M | 3.14M | 3.62M | -713K | 598K | -966K | -2.38M | -4.54M | -2.29M | -4.69M | 2.33M | 3.99M | 1.52M | 4.13M |
Free Cash Flow | -9.82M | -9.52M | -10.02M | -9.19M | -9.77M | -10M | -9.48M | -10.82M | -9.63M | -10.5M | -10.37M | -9.53M | -9.87M | -8.43M | -7.2M | -7.13M | -4.84M |